Pravachol and Bisacodyl drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Pravachol (pravastatin sodium) and Bisacodyl (bisacodyl). Common drug interactions include nausea among females and diarrhoea among males.

The phase IV clinical study analyzes what interactions people have when they take Pravachol and Bisacodyl. It is created by eHealthMe based on reports of 72 people who take the same drugs from the FDA, and is updated regularly.

What is Pravachol?

Pravachol has active ingredients of pravastatin sodium. It is often used in high blood cholesterol. eHealthMe is studying from 24,382 Pravachol users. Check the latest studies of Pravachol.

What is Bisacodyl?

Bisacodyl has active ingredients of bisacodyl. It is often used in constipation. eHealthMe is studying from 18,852 Bisacodyl users. Check the latest studies of Bisacodyl.



On Jul, 17, 2026

72 people who take Pravachol and Bisacodyl together, and have interactions are studied.

Pravachol and Bisacodyl drug interactions.

What are the common drug interactions of Pravachol and Bisacodyl, by gender? *:

female:

  1. Nausea (feeling of having an urge to vomit)
  2. Fall
  3. Injury
  4. Sinusitis (inflammation of sinus)
  5. Chronic kidney disease
  6. Cough
  7. Diarrhoea
  8. Gait disturbance
  9. Gastritis (inflammation of stomach)
  10. Osteoarthritis (a joint disease caused by cartilage loss in a joint)

male:

  1. Diarrhoea
  2. Cough
  3. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  4. Atelectasis (partial or complete collapse of the lung)
  5. Cardiomegaly (increased size of heart than normal)
  6. Chest pain
  7. Cystitis (inflammation of the wall of the bladder)
  8. Diverticulum intestinal (a pouch that is attached to the first part of the small intestine)
  9. Foot fracture
  10. Gait disturbance

What are the common drug interactions of Pravachol and Bisacodyl, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Death
  4. Depression
  5. Anxiety disorder
  6. Arthralgia (joint pain)
  7. Back pain
  8. Bipolar i disorder (mood disorder that is characterized by at least one manic or mixed episode)
  9. Chest pain
  10. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)

50-59:

  1. Aortic arteriosclerosis (hardening of the aortic arteries)
  2. Atelectasis (partial or complete collapse of the lung)
  3. Back pain
  4. Blood urea nitrogen/creatinine ratio increased
  5. Bronchopleural fistula
  6. Cardiomegaly (increased size of heart than normal)
  7. Cerebrovascular disorder (disease of brain)
  8. Cervical spinal stenosis (narrowing of the spinal canal in the neck)
  9. Chest pain
  10. Chondromalacia (anterior knee pain due to irritation of the cartilage on the under surface of the kneecap)

60+:

  1. Asthenia (weakness)
  2. Diarrhoea
  3. Back pain
  4. Balance disorder
  5. Chronic kidney disease
  6. Dehydration (dryness resulting from the removal of water)
  7. Dysphagia (a condition in which swallowing is difficult or painful)
  8. Fatigue (feeling of tiredness)
  9. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  10. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)

What are the existing conditions these people have? *

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 13 people, 18.06%
  2. Pain: 10 people, 13.89%
  3. High Blood Pressure: 8 people, 11.11%
  4. Bone Density Abnormal: 8 people, 11.11%
  5. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 7 people, 9.72%
  6. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 7 people, 9.72%
  7. Urinary Tract Infection: 6 people, 8.33%
  8. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 6 people, 8.33%
  9. Stress And Anxiety: 5 people, 6.94%
  10. Osteoporosis (bones weak and more likely to break): 5 people, 6.94%

* Approximation only. Some reports may have incomplete information.

Do you take Pravachol and Bisacodyl?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Pravachol and Bisacodyl:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Pravachol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Bisacodyl:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Pravachol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Bisacodyl and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on pravastatin sodium and bisacodyl (the active ingredients of Pravachol and Bisacodyl, respectively), and Pravachol and Bisacodyl (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: